KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Exact Sciences (EXAS) EBIT Margin (2016 - 2025)

Historic EBIT Margin for Exact Sciences (EXAS) over the last 17 years, with Q3 2025 value amounting to 3.0%.

  • Exact Sciences' EBIT Margin rose 25600.0% to 3.0% in Q3 2025 from the same period last year, while for Sep 2025 it was 32.45%, marking a year-over-year decrease of 235300.0%. This contributed to the annual value of 38.01% for FY2024, which is 294100.0% down from last year.
  • Exact Sciences' EBIT Margin amounted to 3.0% in Q3 2025, which was up 25600.0% from 0.26% recorded in Q2 2025.
  • In the past 5 years, Exact Sciences' EBIT Margin ranged from a high of 1.09% in Q3 2023 and a low of 122.84% during Q4 2024
  • For the 5-year period, Exact Sciences' EBIT Margin averaged around 26.93%, with its median value being 16.74% (2024).
  • Its EBIT Margin has fluctuated over the past 5 years, first skyrocketed by 422500bps in 2021, then tumbled by -1123500bps in 2024.
  • Over the past 5 years, Exact Sciences' EBIT Margin (Quarter) stood at 46.74% in 2021, then surged by 54bps to 21.5% in 2022, then skyrocketed by 51bps to 10.49% in 2023, then crashed by -1071bps to 122.84% in 2024, then surged by 98bps to 3.0% in 2025.
  • Its last three reported values are 3.0% in Q3 2025, 0.26% for Q2 2025, and 13.58% during Q1 2025.